Table 1 Demographic, clinical, and spectroscopic data of the studied groups
From: Value of magnetic resonance spectroscopy in geriatric patients with cognitive impairment
| Â | I No. 20 | II No. 23 | III No. 15 | IV No.15 | P value | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Age in years | 0.074 | |||||||||
Mean ± SD | 67.5 ± 4.3 | 64.9 ± 3.1 | 64.3 ± 3.7 | 64.4 ± 3.2 | ||||||
Male | No. | 9 | 13 | 7 | 9 | 0.233 | ||||
% | 45 | 56.5 | 46.7 | 60 | ||||||
Female | No. | 11 | 10 | 8 | 6 | |||||
% | 55 | 43.5 | 53.3 | 40 | ||||||
Hippo NAA | I vs II P = 0.000 | I vs IV P = 0.000 | II vs III P = 0.000 | III vs IV P = 0.000 | Â | |||||
Mean ± SD | 6.7 ± 1 | 10.6 ± 0.5 | 7.5 ± 1.5 | 10.9 ± 0.8 | ||||||
Hippo Cr. | Â | |||||||||
Mean ± SD | 5.1 ± 0.4 | 4.9 ± 0.2 | 4.8 ± 0.2 | 4.9 ± 0.2 | ||||||
Hippo NAA/Cr | I vs II P = 0.000 | I vs IV P = 0.000 | II vs III P = 0.000 | III vs IV P = 0.000 | Â | |||||
Mean ± SD | 1.3 ± 0.2 | 2.1 ± 0.1 | 1.5 ± 0.2 | 2.2 ± 0.1 | ||||||
Frontal NAA | I vs III P = 0.000 | I vs IV P = 0.000 | II vs IV P = 0.000 | III vs IV P = 0.011 | Â | |||||
Mean ± SD | 7.7 ± 1.4 | 8.4 ± 1.6 | 9.7 ± 1.3 | 11.4 ± 0.6 | ||||||
Frontal Cr. | Â | |||||||||
Mean ± SD | 4.9 ± 0.2 | 5.1 ± 0.4 | 4.9 ± 0.2 | 4.8 ± 0.2 | ||||||
Frontal NAA/Cr | I vs III P = 0.000 | I vs IV P = 0.000 | II vs III P = 0.002 | II vs IV P = 0.000 | III vs IV P = 0.002 | |||||
Mean ± SD | 1.6 ± 0.3 | 1.7 ± 0.3 | 1.9 ± 0.3 | 2.4 ± 0.2 | ||||||
GDS | I vs II P = 0.000 | II vs III P = 0.000 | II vs IV P = 0.000 | Â | Â | |||||
Mean ± SD | 3.1 ± 1.4 | 10.3 ± 2.5 | 2.1 ± 1 | 1.7 ± 0.7 | ||||||
MoCA | I vs II P = 0.000 | I vs III P = 0.000 | I vs IV P = 0.000 | II vs IV P = 0.000 | III vs IV P = 0.000 | |||||
Mean ±SD | 8.6 ± 4.6 | 20.3 ± 2 | 22.7 ± 2.4 | 27.9 ± 1 | ||||||